Fibrinogen, fibrin and its degradation products in drained blood after major orthopaedic surgery

Blood Coagulation and Fibrinolysis

Volumn 10, Issue 4, 1999, Pages 167-171

  Krohn, Claus Danckert ^a,b   Reikeras O ^a   Bjornsen S ^a   Brosstad, F ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Autologous transfusion; D dimers; Fibrinogen; Fibrinolysis; Immunoblotting; Orthopaedic surgery

Indexed keywords

D DIMER; FIBRIN; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; HEMOGLOBIN;

ADOLESCENT; ADULT; ARTERIAL BLOOD; BLOOD; BLOOD AUTOTRANSFUSION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FIBRINOLYSIS; HEMODILUTION; HUMAN; HUMAN TISSUE; IDIOPATHIC SCOLIOSIS; ORTHOPEDIC SURGERY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; THORACIC SPINE; WOUND CLOSURE;

EID: 0032767859     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199906000-00002     Document Type: Review

References (23)

1. 1. Faris PM, Ritter MA, Keating EM, Valeri CR. Unwashed filtered shed blood collected after knee and hipjoint arthroplasties. J Bone Joint Surg 1991; 73: 1169-1178.
2. 2. Wixson RL, Kwaan HC, Spies SM, Zimmer AM. Reinfusion of postoperative wound drainage in total joint arthroplasty. J Arthroplasty 1994; 9: 351-358.
3. 3. Schönberg JPAM, van Oeveren W, Bredée JJ, Everts PAM, de Haan J, Wildevuur CRH. Systemic blood activation during and after blood autotransfusion. Ann Thorac Surg 1994; 57: 1256-1262.
4. 4. Blevins FT, Shaw B, Valeri CR, Kasser J, Hall J. Reinfusion of shed blood after orthopaedic procedures in children and adolescents. J Bone Joint Surg 1993; 75A: 363-371.
5. 5. Dzik WH, Sherburne B. Intraoperative blood salvage: medical controversies. Transfus Med Rev 1990; 4: 208-235.
6. 6. Thorsen LI, Brosstad F, Gogstad G, Sletten K, Solum NO. Competition between fibrinogen with its degradation products for interaction with the platelet-fibrinogen receptor. Thromb Res 1986; 44: 611-623.
7. 7. Clauss A. Gerinnungsphysiologische Schnellmetode zur Bestimmung des Fibrinogens. Act Haematolog (Basel) 1957; 17: 237-246.
8. 8. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
9. 9. Grøn B, Bennick A, Nieuwenhuizen W, Bjørnsen S, Brosstad F. Immunovisualization of fibrinogen Aα-chain heterogeneity in normal plasma from patients with DIC or streptokinase therapy. Thromb Res 1988; 52: 413-424.
10. 10. Dalèn T, Broström LÅ, Engström KG. Cell quality of salvaged blood after knee arthroplasty. Act Orthopaed Scand 1995; 66: 329-333.
11. 11. Krohn CD, Bjerkreim I. Per-and postoperative autologous transfusion in orthopaedic surgery. Tidsskr Nor Lægeforen 1995; 115: 2395-2397.
12. 12. Murray DJ, Olson J, Strauss R, Tinker JH. Coagulation changes during packed red cell replacement of major blood loss. Anaesthesiology 1988; 69: 839-845.
13. 13. Dahl OE, Molnar I, Rø JS, Vinje A. Global tests on coagulation and fibrinolysis in systemic and pulmonary circulation accompanying hip arthroplasty with acrylic cement. Thromb Res 1988; 50: 865-873.
14. 14. Marder VJ, Machett MO, Sherry S. Detection of serum fibrinogen and fibrin degradation products. Comparison of six techniques using purified products and application in clinical studies. Am J Med 1971; 51: 71-76.
15. 15. Marder VJ, Schulman NR, Carroll WR. The importance of intermediate degradation products of fibrinogen in fibrinolytic haemorrhage. Trans Assoc Am Phys 1967; 80: 156-167.
16. 16. Larrieu MI, Rigollot C, Marder VJ. Comparative effects of fibrinogen degradation fragments D and E on coagulation. Br J Haematol 1972; 22: 719-733.
17. 17. Hirsch J, Fletcher AP, Sherry S. Effect of fibrin and fibrinogen proteolysis products on clot physical properties. Am J Physiol 1965; 209: 415-420.
18. 18. Godal HC, Helle I. The influence of fibrinogenolytic and fibrinolytic split products on the last step of coagulation. Scand J Clin Lab Invest 1963; 15: 327-338.
19. 19. Haverkate F, Timan G, Nieuwenhuizen W. Anti-clotting properties of fragment D form human fibrinogen and fibrin. Eur J Clin Invest 1979; 9: 253-255.
20. 20. Nieuwenhuizen W, Voskuilen M, Hermans J. Anticoagulant and calcium-binding properties of high molecular weight derivatives of human fibrinogen (plasmin fragments Y). Biochim Biophys Acta 1982; 708: 313-316.
21. 21. Arnesen H. The effect of products D and E on thrombin induced conversion of fibrinogen to fibrin. Scand J Haematol 1974; 12: 165-172.
22. 22. Kowalsky E, Kopec M, Wegrzynowich Z. Influence of fibrinogen degradation products (FDP) on platelet aggregation, adhesiveness and viscous metamorphosis. Thromb Diathes Haemorrh 1963; 10: 406-412.
23. 125I-labelled fibrin(ogen) to platelets and to immunoprecipitated glycoprotein IIb-IIIa complex. Thromb Res 1986; 42: 645-659.